PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-8.89%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-8.13%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-13.11%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-12.58%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-73.23%
Negative net income growth while ON stands at 387.49%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-72.87%
Negative EPS growth while ON is at 380.77%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-73.02%
Negative diluted EPS growth while ON is at 388.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.30%
Share reduction while ON is at 0.50%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.10%
Reduced diluted shares while ON is at 1.36%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
23.81%
Dividend growth of 23.81% while ON is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
12.02%
Positive OCF growth while ON is negative. John Neff would see this as a clear operational advantage vs. the competitor.
10.55%
Positive FCF growth while ON is negative. John Neff would see a strong competitive edge in net cash generation.
46.89%
10Y revenue/share CAGR under 50% of ON's 146.18%. Michael Burry would suspect a lasting competitive disadvantage.
42.24%
5Y revenue/share CAGR under 50% of ON's 114.11%. Michael Burry would suspect a significant competitive gap or product weakness.
21.89%
3Y revenue/share CAGR under 50% of ON's 63.75%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
88.82%
10Y OCF/share CAGR 1.25-1.5x ON's 63.18%. Bruce Berkowitz would confirm if the firm's long-term capital allocation yields better cash returns.
100.89%
5Y OCF/share CAGR 1.25-1.5x ON's 73.61%. Bruce Berkowitz would see if capital spending or working-capital efficiencies explain the difference.
61.14%
3Y OCF/share CAGR 1.25-1.5x ON's 41.80%. Bruce Berkowitz might see if strategic cost controls or product mix drove recent gains.
-36.54%
Negative 10Y net income/share CAGR while ON is at 532.21%. Joel Greenblatt sees a major red flag in long-term profit erosion.
47.24%
Below 50% of ON's 505.39%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-55.69%
Negative 3Y CAGR while ON is 11009.94%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
44.34%
Below 50% of ON's 12639.93%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
6.56%
Below 50% of ON's 115.85%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
5.71%
Below 50% of ON's 74.92%. Michael Burry suspects a serious short-term disadvantage in building book value.
516.71%
Stable or rising dividend while ON is cutting. John Neff sees a strong advantage in consistent shareholder returns vs. a struggling peer.
193.79%
Dividend/share CAGR of 193.79% while ON is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
82.37%
3Y dividend/share CAGR of 82.37% while ON is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-18.91%
Firm’s AR is declining while ON shows 0.85%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
2.57%
Inventory shrinking or stable vs. ON's 5.88%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
4.21%
Asset growth at 75-90% of ON's 4.86%. Bill Ackman suggests reviewing opportunities to match or surpass the competitor's asset expansion if profitable.
-5.64%
We have a declining book value while ON shows 24.68%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
13.79%
Debt growth far above ON's 0.30%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
2.93%
R&D growth drastically higher vs. ON's 4.71%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-0.73%
We cut SG&A while ON invests at 2.58%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.